Shanghai Shen Lian Biomedical Corporation: Intensified competition weakens the leading profit of pig vaccines, will expand new product development | Directly hit earnings conference

1. Affected by the sluggish downstream livestock breeding market and price decline, the leading pig vaccine maker Shanghai Shen Lian Biomedical Corporation experienced an increase in revenue but not in profit; 2. Nie Dongsheng stated at the earnings conference that in the second half of 2024, Shanghai Shen Lian Biomedical Corporation will timely adjust short-term, medium-term, and long-term operating goals, expand market development and global strategic layout of new products, including cattle and sheep foot-and-mouth disease inactivated vaccines, increase the sales proportion of pig circovirus vaccines, and at the same time, have products entering the supply chain system of multiple large-scale breeding groups.

cls.cnOct 21 06:34 ET

The animal protection industry is under pressure, with pulike biological engineering,inc. H1 net profit falling by more than thirty percent. The pet track may become a new growth point. | Interpretations

① The net income of the animal protection industry in H1 generally declined, with Pulike Biological Engineering, Inc. declining by more than 30%, but the company's Q2 net income has narrowed compared to Q1; ② The company's pet track has made a breakthrough in H1 and may become a new growth point for future performance; ③ Looking ahead to the second half of the year, when the downstream animal husbandry industry's profits rebound, the upstream animal protection enterprises' profits will also show an upward trend.

cls.cnAug 29 10:37 ET

Levi Strauss' Strong Business Model To Drive Growth In 2023, Says Analyst

BenzingaApr 6, 2023 13:20 ET

FedEx Says DRIVE Transformation Is Expected To Generate $4B In Permanent Cost Reductions In FY25

BenzingaApr 5, 2023 07:36 ET

Google Finally Listens To User Complaints: Rolls Back 5M Item Limit On Drive

BenzingaApr 4, 2023 02:37 ET

Fed's Williams Says GDP Will Soften Modestly This Year Before Rebounding In 2023; The View Of Financial Conditions Will Be Crucial In Monetary Policy Thinking; Uncertain Economic Outlook And Economic Data Will Drive Monetary Policy Outlook

BenzingaMar 31, 2023 15:14 ET